Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
506
Frequently Asked Questions
What is Market Cap of Adaptimmune Therapeutics Plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adaptimmune Therapeutics Plc - ADR market cap is $33.66M.
What is the 52-week high for Adaptimmune Therapeutics Plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adaptimmune Therapeutics Plc - ADR 52 week high is $1.01 as of September 26, 2025.
What is the 52-week low for Adaptimmune Therapeutics Plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adaptimmune Therapeutics Plc - ADR 52 week low is $0.0403 as of September 26, 2025.
What is Adaptimmune Therapeutics Plc - ADR stock price today?
Adaptimmune Therapeutics Plc - ADR stock price today is $0.147.
What was Adaptimmune Therapeutics Plc - ADR stock price yesterday?
Adaptimmune Therapeutics Plc - ADR stock price yesterday was $0.127.
What is the PE ratio of Adaptimmune Therapeutics Plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Adaptimmune Therapeutics Plc - ADR’s P/E ratio is -0.19.
What is the Price-to-Book ratio of Adaptimmune Therapeutics Plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Adaptimmune Therapeutics Plc - ADR P/B ratio is -0.4744.
What is the 50-day moving average of Adaptimmune Therapeutics Plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adaptimmune Therapeutics Plc - ADR 50-day moving average is $0.1101.
How many employess does Adaptimmune Therapeutics Plc - ADR has?
Adaptimmune Therapeutics Plc - ADR has 506 employees.